Rare lephants
Screener

Eli Lilly & Co.

LLY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B2 May 6, 2026 424B2
SCHEDULE 13G May 1, 2026
10-Q Apr 30, 2026 10-Q
8-K Apr 30, 2026 8-K
PX14A6G Apr 29, 2026
4 Apr 21, 2026 FORM 4
4 Apr 21, 2026 FORM 4
4 Apr 21, 2026 FORM 4
4 Apr 21, 2026 FORM 4
SCHEDULE 13G/A Apr 20, 2026
DFAN14A Mar 31, 2026 DFAN14A
SCHEDULE 13G/A Mar 26, 2026
DEFA14A Mar 20, 2026 DEFA14A
DEF 14A Mar 20, 2026 DEF 14A
4 Mar 17, 2026 FORM 4
4 Mar 17, 2026 FORM 4
4 Mar 17, 2026 FORM 4
4 Mar 17, 2026 FORM 4
PRE 14A Mar 6, 2026 PRE 14A
4 Feb 19, 2026 FORM 4
4 Feb 18, 2026 FORM 4
4 Feb 18, 2026 FORM 4
4 Feb 18, 2026 FORM 4
4 Feb 18, 2026 FORM 4
4 Feb 18, 2026 FORM 4
← Newer Page 3 of 154 · 3826 filings Older →